OPN4
gene geneOn this page
Also known as MOPmelanopsin
Summary
OPN4 (opsin 4, HGNC:14449) is a protein-coding gene on chromosome 10q23.2, encoding Melanopsin (Q9UHM6). Photoreceptor that binds cis-retinaldehydes.
Opsins are members of the guanine nucleotide-binding protein (G protein)-coupled receptor superfamily. This gene encodes a photoreceptive opsin protein that is expressed within the ganglion and amacrine cell layers of the retina. In mouse, retinal ganglion cell axons expressing this gene projected to the suprachiasmatic nucleus and other brain nuclei involved in circadian photoentrainment. In mouse, this protein is coupled to a transient receptor potential (TRP) ion channel through a G protein signaling pathway and produces a physiologic light response via membrane depolarization and increased intracellular calcium. The protein functions as a sensory photopigment and may also have photoisomerase activity. Experiments with knockout mice indicate that this gene attenuates, but does not abolish, photoentrainment. Alternative splicing results in multiple transcript variants encoding different isoforms.
Source: NCBI Gene 94233 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 104 total
- MANE Select transcript:
NM_033282
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14449 |
| Approved symbol | OPN4 |
| Name | opsin 4 |
| Location | 10q23.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MOP, melanopsin |
| Ensembl gene | ENSG00000122375 |
| Ensembl biotype | protein_coding |
| OMIM | 606665 |
| Entrez | 94233 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 2 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000241891, ENST00000372071, ENST00000686083, ENST00000690949
RefSeq mRNA: 2 — MANE Select: NM_033282
NM_001030015, NM_033282
CCDS: CCDS31237, CCDS7376
Canonical transcript exons
ENST00000241891 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003843370 | 86665713 | 86666460 |
| ENSE00003845915 | 86654547 | 86654927 |
| ENSE00003922585 | 86662252 | 86662432 |
| ENSE00003923798 | 86663659 | 86663802 |
| ENSE00003925250 | 86659297 | 86659468 |
| ENSE00003927154 | 86658484 | 86658687 |
| ENSE00003930476 | 86659895 | 86660059 |
| ENSE00003931250 | 86656155 | 86656300 |
| ENSE00003933505 | 86661281 | 86661388 |
| ENSE00003935014 | 86658032 | 86658165 |
Expression profiles
Bgee: expression breadth ubiquitous, 105 present calls, max score 68.55.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2006 / max 27.3834, expressed in 70 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 105966 | 0.1316 | 54 |
| 105967 | 0.0689 | 36 |
Top tissues by expression
233 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| gastrocnemius | UBERON:0001388 | 68.55 | gold quality |
| muscle of leg | UBERON:0001383 | 67.39 | gold quality |
| putamen | UBERON:0001874 | 65.01 | gold quality |
| nucleus accumbens | UBERON:0001882 | 63.89 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 62.19 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 62.09 | gold quality |
| caudate nucleus | UBERON:0001873 | 61.81 | gold quality |
| endothelial cell | CL:0000115 | 59.67 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 58.49 | gold quality |
| prefrontal cortex | UBERON:0000451 | 58.13 | gold quality |
| heart left ventricle | UBERON:0002084 | 57.78 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 57.33 | gold quality |
| cardiac ventricle | UBERON:0002082 | 57.18 | gold quality |
| oocyte | CL:0000023 | 56.76 | gold quality |
| right atrium auricular region | UBERON:0006631 | 56.67 | gold quality |
| cardiac atrium | UBERON:0002081 | 56.25 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 55.80 | gold quality |
| neocortex | UBERON:0001950 | 55.51 | gold quality |
| apex of heart | UBERON:0002098 | 55.41 | gold quality |
| jejunal mucosa | UBERON:0000399 | 55.17 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 55.08 | gold quality |
| frontal cortex | UBERON:0001870 | 54.78 | gold quality |
| right frontal lobe | UBERON:0002810 | 53.85 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 53.76 | gold quality |
| heart | UBERON:0000948 | 53.73 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 53.57 | gold quality |
| cerebral cortex | UBERON:0000956 | 53.41 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 53.21 | gold quality |
| forebrain | UBERON:0001890 | 53.12 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 53.12 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.28 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
37 targeting OPN4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-4283 | 100.00 | 66.42 | 2097 |
| HSA-MIR-34A-5P | 99.99 | 71.21 | 1784 |
| HSA-MIR-449A | 99.99 | 71.05 | 1776 |
| HSA-MIR-34C-5P | 99.97 | 70.45 | 1577 |
| HSA-MIR-449B-5P | 99.97 | 70.26 | 1580 |
| HSA-MIR-4487 | 99.96 | 64.58 | 1252 |
| HSA-MIR-185-3P | 99.95 | 67.01 | 1743 |
| HSA-MIR-1343-3P | 99.89 | 66.78 | 1815 |
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-636 | 99.80 | 69.58 | 1500 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-6883-5P | 99.69 | 68.05 | 3785 |
| HSA-MIR-762 | 99.58 | 66.61 | 1994 |
| HSA-MIR-7106-5P | 99.53 | 67.47 | 3574 |
| HSA-MIR-486-3P | 99.51 | 66.82 | 1901 |
| HSA-MIR-4498 | 99.47 | 67.42 | 2360 |
| HSA-MIR-6852-5P | 99.17 | 66.69 | 2073 |
| HSA-MIR-6799-5P | 99.14 | 65.72 | 2093 |
| HSA-MIR-5001-5P | 99.05 | 66.76 | 1972 |
| HSA-MIR-939-3P | 98.97 | 65.07 | 2347 |
| HSA-MIR-10A-5P | 98.89 | 69.85 | 712 |
| HSA-MIR-4764-5P | 98.88 | 65.53 | 894 |
Literature-anchored findings (GeneRIF, showing 35)
- melanopsin acts as a sensory photopigment, coupled to a native ion channel via a G-protein signalling cascade, to drive physiological light detection (PMID:15674244)
- an anatomically distinct population of ‘giant’, melanopsin-expressing ganglion cells in the primate retina that, in addition to being intrinsically photosensitive, are strongly activated by rods and cones (PMID:15716953)
- Regulation of melanopsin expression [review] (PMID:16687290)
- HEK293 cells stably expressing melanopsin have proven to be a useful tool to study melanopsin-initiated signaling. (PMID:16961436)
- Data show that Seasonal Affective Disorder participants have a higher frequency of the melanopsin (OPN4) homozygous minor genotype (T/T) for the missense variant rs2675703 (P10L) than controls, compared to the combined frequencies of C/C and C/T. (PMID:18804284)
- The recent advances in the emerging roles of melanopsin and intrinsically photosensitive retinal ganglion cells, are reviewed. (PMID:20810319)
- Melanopsin and mechanisms of non-visual ocular photoreception (PMID:22074930)
- the results indicate that ectopic expression of human OPN4 in orexin neurons enables long-lasting activation of orexin neurons by blue light to control sleep/wakefulness of the mice. (PMID:22868039)
- These results suggest that the P10L TT genotype of melanopsin interacts with daylength to predispose individuals to vary in sleep onset and chronotype as a function of daylength. (PMID:22881342)
- The relative contribution of melanopsin and visual photoreceptors are assessed by comparing pupillary light reflex responses in a totally visually blind patient with normally sighted individuals. (PMID:23055493)
- An action spectrum for the calcium response in cells expressing human melanopsin had the predicted form for an opsin : vitamin A1 pigment and peaked at 479 nm. The G-protein selectivity and spectral sensitivity of human melanopsin is similar to that previously described for rodents. (PMID:23554393)
- Significant interaction between the genotype of I394T (TT versus TC+CC) and luminance levels was found in pupil size. (PMID:23555953)
- The results of this study showed that the post illumination pupil response varied on the basis of OPN4 I394T genotype among individuals with seasonal affective disorder. (PMID:23809464)
- Studied the association between melanopsin gene polymorphism and pupillary light reflex under diverse photic conditions, including different intensities and wavelengths. (PMID:24119231)
- A comparison of melanopsin with the mechanisms documented for vertebrate (bovine) and invertebrate (squid) visual photoreceptors shows that such a mechanism is not affected by the diversity of the three chromophore cavities. (PMID:24449866)
- Studied OPN4*Ile394Thr gene polymorphism in association with sleep/wake timing. (PMID:24887407)
- The light-induced FOS response in melanopsin expressing HEK-293 cells is correlated with melanopsin quantity and dependent on light duration and irradiance. (PMID:24909488)
- The response of the human pupil to the separate stimulation of the cones and melanopsin at a range of temporal frequencies under photopic conditions, was measured. (PMID:25313040)
- By broadening the tuning of intrinsically photosensitive retinal ganglion cells, melanopsin tristability produces signal integration. (PMID:25741728)
- Trait-like individual differences in the melanopsin phototransduction circuitry contribute to individual differences in sleep timing. Blue light-sensitive young individuals are more prone to delayed sleep. (PMID:27091519)
- The wide distribution of OPN4 in central areas of the human brain evokes a question whether ambient light has important straight targets in the human brain outside the retinohypothalamic tract. (PMID:27690288)
- Seeing the light to change colour: An evolutionary perspective on the role of melanopsin in neuroendocrine circuits regulating light-mediated skin pigmentation. (PMID:29239123)
- Valuable insight into the structure-function relationships of human melanopsin, including several key functional residues of the melanopsin protein. The identification of melanopsin variants with significantly altered function may serve to detect individuals with disrupted melanopsin-based light perception, and potentially highlight those at increased risk of sleep disturbance, circadian dysfunction, and visual disorders. (PMID:29700553)
- Melanopsin Thr394Ile and Pro10Leu single-nucleotide polymorphisms are directly associated with altered melanopsin signaling. (PMID:29718372)
- A quantitative analysis of the contribution of melanopsin to brightness perception. (PMID:31110303)
- OPN4 (Melanopsin) in retinal ganglion cells has roles in aging and disease [review] (PMID:31219170)
- OPN4 belongs to the photosensitive system of the human skin. (PMID:31989708)
- Targeting Opsin4/Melanopsin with a Novel Small Molecule Suppresses PKC/RAF/MEK/ERK Signaling and Inhibits Lung Adenocarcinoma Progression. (PMID:32269074)
- Melanopsin mediates UVA-dependent modulation of proliferation, pigmentation, apoptosis, and molecular clock in normal and malignant melanocytes. (PMID:32645331)
- Association of P10L Polymorphism in Melanopsin Gene with Chronic Insomnia in Mexicans. (PMID:33445464)
- Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3. (PMID:34035222)
- Melanopsin (Opn4) is an oncogene in cutaneous melanoma. (PMID:35562405)
- The melanopsin-mediated pupil response is reduced in idiopathic hypersomnia with long sleep time. (PMID:35637236)
- Melanopsin-mediated amplification of cone signals in the human visual cortex. (PMID:38808443)
- Melanopsin in the human and chicken choroid. (PMID:39151779)
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | opn4a | ENSDARG00000022098 |
| danio_rerio | opn4b | ENSDARG00000053929 |
| mus_musculus | Opn4 | ENSMUSG00000021799 |
| rattus_norvegicus | Opn4 | ENSRNOG00000053893 |
| drosophila_melanogaster | ninaE | FBGN0002940 |
| drosophila_melanogaster | Rh2 | FBGN0003248 |
| drosophila_melanogaster | Rh3 | FBGN0003249 |
| drosophila_melanogaster | Rh4 | FBGN0003250 |
| drosophila_melanogaster | Rh5 | FBGN0014019 |
Paralogs (9): OPN3 (ENSG00000054277), OPN1LW (ENSG00000102076), OPN5 (ENSG00000124818), OPN1SW (ENSG00000128617), RHO (ENSG00000163914), OPN1MW2 (ENSG00000166160), RRH (ENSG00000180245), OPN1MW (ENSG00000268221), OPN1MW3 (ENSG00000269433)
Protein
Protein identifiers
Melanopsin — Q9UHM6 (reviewed: Q9UHM6)
Alternative names: Opsin-4
All UniProt accessions (1): Q9UHM6
UniProt curated annotations — full annotation on UniProt →
Function. Photoreceptor that binds cis-retinaldehydes. Contributes to pupillar reflex, photoentrainment and other non-image forming responses to light. May be involved in the optokinetic visual tracking response. May be involved in the regulation of retinal hyaloid vessel growth and regression.
Subcellular location. Cell membrane. Cell projection. Axon. Dendrite. Perikaryon.
Tissue specificity. Expressed in the retina.
Similarity. Belongs to the G-protein coupled receptor 1 family. Opsin subfamily.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9UHM6-1 | 1 | yes |
| Q9UHM6-2 | 2 |
RefSeq proteins (2): NP_001025186, NP_150598* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR001760 | Opsin | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
| IPR027430 | Retinal_BS | Binding_site |
| IPR050125 | GPCR_opsins | Family |
Pfam: PF00001
UniProt features (26 total): topological domain 8, transmembrane region 7, sequence variant 3, region of interest 2, compositionally biased region 2, chain 1, modified residue 1, disulfide bond 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UHM6-F1 | 74.78 | 0.52 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 340
Disulfide bonds (1): 143–221
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-416476 | G alpha (q) signalling events |
| R-HSA-419771 | Opsins |
MSigDB gene sets: 98 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN, GOBP_CIRCADIAN_RHYTHM, GOBP_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS, GOBP_BEHAVIOR, GOBP_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS, GOBP_PHOTOTRANSDUCTION, GOBP_REGULATION_OF_CIRCADIAN_RHYTHM, GOBP_TAXIS, GOBP_ANATOMICAL_STRUCTURE_REGRESSION, GOBP_DETECTION_OF_TEMPERATURE_STIMULUS, GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS, MARTIN_NFKB_TARGETS_UP, MARTIN_VIRAL_GPCR_SIGNALING_UP, GOBP_RESPONSE_TO_RADIATION, GOBP_DETECTION_OF_LIGHT_STIMULUS
GO Biological Process (13): G protein-coupled receptor signaling pathway (GO:0007186), visual perception (GO:0007601), phototransduction (GO:0007602), optokinetic behavior (GO:0007634), regulation of circadian rhythm (GO:0042752), thermotaxis (GO:0043052), rhythmic process (GO:0048511), detection of temperature stimulus involved in thermoception (GO:0050960), retina development in camera-type eye (GO:0060041), cellular response to light stimulus (GO:0071482), hyaloid vascular plexus regression (GO:1990384), signal transduction (GO:0007165), detection of visible light (GO:0009584)
GO Molecular Function (5): 11-cis retinal binding (GO:0005502), G protein-coupled photoreceptor activity (GO:0008020), G protein-coupled receptor activity (GO:0004930), protein binding (GO:0005515), photoreceptor activity (GO:0009881)
GO Cellular Component (8): plasma membrane (GO:0005886), membrane (GO:0016020), axon (GO:0030424), dendrite (GO:0030425), perikaryon (GO:0043204), photoreceptor disc membrane (GO:0097381), sperm head plasma membrane (GO:1990913), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| GPCR downstream signalling | 1 |
| Class A/1 (Rhodopsin-like receptors) | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| G protein-coupled receptor activity | 2 |
| signal transduction | 2 |
| detection of light stimulus | 2 |
| camera-type eye development | 2 |
| neuron projection | 2 |
| sensory perception of light stimulus | 1 |
| visual behavior | 1 |
| circadian rhythm | 1 |
| regulation of biological process | 1 |
| response to temperature stimulus | 1 |
| taxis | 1 |
| biological_process | 1 |
| thermoception | 1 |
| detection of temperature stimulus involved in sensory perception | 1 |
| anatomical structure development | 1 |
| response to light stimulus | 1 |
| cellular response to radiation | 1 |
| anatomical structure regression | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| retinal binding | 1 |
| detection of visible light | 1 |
| photoreceptor activity | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| binding | 1 |
| signaling receptor activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| dendritic tree | 1 |
| neuronal cell body | 1 |
| photoreceptor outer segment | 1 |
| organelle membrane | 1 |
| sperm head | 1 |
| sperm plasma membrane | 1 |
| plasma membrane region | 1 |
Protein interactions and networks
STRING
1324 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OPN4 | CNGA3 | Q16281 | 941 |
| OPN4 | GNAT1 | P11488 | 895 |
| OPN4 | AANAT | Q16613 | 853 |
| OPN4 | GLYATL1 | Q969I3 | 851 |
| OPN4 | RPE65 | Q16518 | 849 |
| OPN4 | GNAT2 | P19087 | 822 |
| OPN4 | LRAT | O95237 | 782 |
| OPN4 | CNGB3 | Q9NQW8 | 739 |
| OPN4 | PDE6C | P51160 | 731 |
| OPN4 | PER2 | O15055 | 727 |
| OPN4 | FOS | P01100 | 710 |
| OPN4 | POU4F2 | Q12837 | 709 |
| OPN4 | POU4F1 | Q01851 | 694 |
| OPN4 | CRY1 | Q16526 | 679 |
| OPN4 | BMAL1 | O00327 | 679 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| UBQLN2 | OPN4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OPN4 | STX12 | psi-mi:“MI:0914”(association) | 0.350 |
| UBQLN2 | OPN4 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (9): STX12 (Affinity Capture-MS), NDFIP1 (Affinity Capture-MS), STX12 (Affinity Capture-MS), NDFIP1 (Affinity Capture-MS), STX10 (Affinity Capture-MS), UBQLN2 (Two-hybrid), STX12 (Affinity Capture-MS), NDFIP1 (Affinity Capture-MS), OPN4 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: O02300, O08892, O15973, O42490, O46635, O55040, O88319, P08908, P19020, P20789, P28222, P28334, P28564, P30728, P30989, P30994, P31389, P35404, P35462, P46636, P49144, P52703, P53453, P53454, P56496, P60020, P79250, Q02152, Q0EAB5, Q17239, Q1JPS6, Q25321, Q25322, Q588Y6, Q5IS72, Q5XXP2, Q5YKK9, Q6XL69, Q6XXX8, Q6XXX9
Diamond homologs: A0A287A2K5, O01668, O02464, O02465, O15973, O16005, O16017, O16018, O16019, O16020, O18312, O18315, O18481, O18485, O18486, O42427, O57422, O61303, O96107, O97512, P04950, P06002, P08099, P08255, P09241, P17646, P22269, P24603, P28678, P28679, P28680, P29371, P29404, P31356, P32251, P35356, P35360, P35361, P35362, P47937
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
104 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 90 |
| Likely benign | 9 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1849 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:86658685:GGA:G | donor_gain | 1.0000 |
| 10:86658686:GA:G | donor_gain | 1.0000 |
| 10:86658686:GAG:G | donor_gain | 1.0000 |
| 10:86658688:G:GG | donor_gain | 1.0000 |
| 10:86659465:GACG:G | donor_gain | 1.0000 |
| 10:86659466:ACGGT:A | donor_loss | 1.0000 |
| 10:86659467:CGG:C | donor_loss | 1.0000 |
| 10:86659469:GTAA:G | donor_loss | 1.0000 |
| 10:86659470:T:G | donor_loss | 1.0000 |
| 10:86659890:CCTA:C | acceptor_loss | 1.0000 |
| 10:86659892:TA:T | acceptor_loss | 1.0000 |
| 10:86659893:AG:A | acceptor_gain | 1.0000 |
| 10:86659894:GG:G | acceptor_gain | 1.0000 |
| 10:86660055:GCTGG:G | donor_gain | 1.0000 |
| 10:86660057:TGGG:T | donor_loss | 1.0000 |
| 10:86660058:GG:G | donor_gain | 1.0000 |
| 10:86660059:GG:G | donor_gain | 1.0000 |
| 10:86660059:GGT:G | donor_loss | 1.0000 |
| 10:86660060:G:GC | donor_loss | 1.0000 |
| 10:86660060:G:GG | donor_gain | 1.0000 |
| 10:86660061:T:A | donor_loss | 1.0000 |
| 10:86661383:G:GG | donor_gain | 1.0000 |
| 10:86663799:G:T | donor_gain | 1.0000 |
| 10:86654928:G:GG | donor_gain | 0.9900 |
| 10:86656314:G:GA | donor_gain | 0.9900 |
| 10:86656358:G:T | donor_gain | 0.9900 |
| 10:86658030:A:AG | acceptor_gain | 0.9900 |
| 10:86658030:AGG:A | acceptor_loss | 0.9900 |
| 10:86658031:G:GG | acceptor_gain | 0.9900 |
| 10:86658031:GGA:G | acceptor_gain | 0.9900 |
AlphaMissense
3096 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:86658663:A:C | S202R | 0.990 |
| 10:86658665:T:A | S202R | 0.990 |
| 10:86658665:T:G | S202R | 0.990 |
| 10:86658132:A:C | S131R | 0.981 |
| 10:86658134:C:A | S131R | 0.981 |
| 10:86658134:C:G | S131R | 0.981 |
| 10:86660007:T:C | F305L | 0.981 |
| 10:86660009:C:A | F305L | 0.981 |
| 10:86660009:C:G | F305L | 0.981 |
| 10:86658660:T:A | W201R | 0.980 |
| 10:86658660:T:C | W201R | 0.980 |
| 10:86658684:T:A | W209R | 0.979 |
| 10:86658684:T:C | W209R | 0.979 |
| 10:86658084:A:C | S115R | 0.977 |
| 10:86658086:C:A | S115R | 0.977 |
| 10:86658086:C:G | S115R | 0.977 |
| 10:86658074:C:A | N111K | 0.974 |
| 10:86658074:C:G | N111K | 0.974 |
| 10:86658687:A:C | S210R | 0.972 |
| 10:86659298:C:A | S210R | 0.972 |
| 10:86659298:C:G | S210R | 0.972 |
| 10:86661335:G:C | K340N | 0.972 |
| 10:86661335:G:T | K340N | 0.972 |
| 10:86661331:C:A | A339D | 0.969 |
| 10:86656274:C:A | N88K | 0.967 |
| 10:86656274:C:G | N88K | 0.967 |
| 10:86658562:G:C | R168P | 0.967 |
| 10:86658642:T:A | W195R | 0.966 |
| 10:86658642:T:C | W195R | 0.966 |
| 10:86656293:T:C | F95L | 0.965 |
dbSNP variants (sampled 300 via entrez): RS1000043043 (10:86659606 G>A), RS1000062127 (10:86666731 G>A), RS1000074284 (10:86659853 C>T), RS1000805825 (10:86662346 C>A,T), RS1000858027 (10:86662160 C>T), RS1001637846 (10:86660408 G>A), RS1001742668 (10:86660956 G>A,C), RS1002190868 (10:86666425 G>A,C), RS1002300039 (10:86661584 G>A,T), RS1002407576 (10:86657391 G>A), RS1002734832 (10:86653459 CAG>C), RS1002739815 (10:86656156 C>T), RS1002749880 (10:86660635 C>A,T), RS1002824626 (10:86661816 C>T), RS1003045310 (10:86660345 G>T)
Disease associations
OMIM: gene MIM:606665 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Opsin receptors
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Diazinon | increases methylation | 1 |
| Plant Extracts | decreases expression, affects cotreatment | 1 |
| Valproic Acid | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.